The aim of this study was to investigate the role of molecular mimicry in the cytokine storms
associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Human …

Aim: To define the autoimmune potential of Severe Acute Respiratory Syndrome
Coronavirus 2 (SARS-CoV-2) infection. Methods: Experimentally validated epitopes …

In addition to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), humans are
also susceptible to six other coronaviruses, for which consecutive exposures to antigenically …

The spike glycoprotein of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)
continues to accumulate substitutions, leading to breakthrough infections of vaccinated …

The serological responses to both SARS-CoV-1 and SARS-CoV-2 virus have some unique
characteristics that suggest cross-reactive priming by other human coronaviruses (hCoVs) …

Beyond the unpredictable acute illness caused by SARS-CoV-2, one-fifth of infections
unpredictably result in long-term persistence of symptoms despite the apparent clearance of …

SARS-CoV-2 is a novel betacoronavirus that caused coronavirus disease 2019 and has
resulted in millions of deaths worldwide. Novel coronavirus infections in humans have …

Background Pre-existing cross-reactive immunity among different coronaviruses, also
termed immune imprinting, may have a comprehensive impact on subsequent SARS-CoV-2 …

Methods Peptide sharing analyses have been extensively described elsewhere [16, 17].
Briefly, SARS-CoV-2 spike glycoprotein (NCBI protein Id= QHD43416. 1) primary sequence …

The severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection and the
associated COVID‐19 diseases are an emerging threat to global public health. Although …